Humoral immune response to Chlamydia pneumoniae in twins discordant for smoking

Journal of Internal Medicine

Volumn 244, Issue 3, 1998, Pages 227-234

  Von Hertzen, L ^a   Kaprio, J ^b   Koskenvuo, M ^c   Isoaho, R ^c   Saikku, P ^d  

^a Finnish Lung Health Association   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Antibodies; Chlamydia pneumoniae and smoking

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FINLAND; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; TWIN DISCORDANCE;

ADULT; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DISEASES IN TWINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; ODDS RATIO; SMOKING;

EID: 0031817941     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hanrahan JP, Sherman CB, Bresnitz EA, Emmons KM, Mannino DM. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861-5.
2. Sherman CB. Health effects of cigarette smoking. Clin Chest Med 1991; 12: 643-58.
3. Holt P. Immune and inflammatory function in cigarette smokers. Thorax 1987; 42: 241-9.
4. Byron KA, Varigos GA, Wootton AM. IL-4 production is increased in cigarette smokers. Clin Exp Immunol 1994; 95: 333-6.
5. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin Microbiol Rev 1996; 9: 532-62.
6. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241-51.
7. Kaufman SH. Immunity to intracellular microbial pathogens. Immun Today 1995; 16: 338-42.
8. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman M-R, Manninen V et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-8.
9. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J et al. Chlamydia pneumoniae: Risk factors for sero-positivity and association with coronary heart disease. J Infect 1995; 30: 121-8.
10. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pnewnoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266: 225-30.
11. von Hertzen L, Alakärppä H, Koskinen R, Liippo K, Surcel H-M, Leinonen M, Saikku P. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997; 118: 155-64.
12. Mabey D, Bailey R. Immunity to Chlamydia trachomatis: lessons from a Gambian village. J Med Microbiol 1996; 45: 1-2.
13. Holland M, Bailey R, Conway D, Culley F, Miranpuri G, Byrne G et al. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PMNC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996; 105: 429-35.
14. Fischer A, König W. Modulation of in vitro immunoglobulin synthesis of human peripheral blood mononuclear cells by nicotine and cotinine. Clin Invest 1994; 72: 225-32.
15. Laughter AH, Martin RR, Twomey JJ. Lymphoproliferative responses to antigens mediated by human pulmonary alveolar macrophages. J Lab Clin Med 1977; 89: 1326-32.
16. von Hertzen L, Surcel H-M, Kaprio J, Koskenvuo M, Bloigu A, Leinonen M, Saikku P. Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking. J Med Microbiol 1998; 47: 441-46.
17. Mårdh PA, Paavonen J, Puolakkainen M. Chlamydia. New York and London: Plenum Medical Book Company, 1989.
18. Tomasi TB, Grey HM. Structure and function of immunoglobulin A. Progr Allergy 1972; 16: 81-113.
19. Brett MM, Ghoneim ATM, Littlewood JM. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child 1990; 65: 259-63.
20. Paltiel O, Kark JD, Leinonen M, Saikku P. High prevalence of antibodies to Chlamydia pneumoniae: determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol Infect 1995; 114: 465-73.
21. Dáhlen GH, Boman J, Birgander LS, Lindblom B. Lp (a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995; 114: 165-74.
22. Karvonen M, Tuomilehto J, Pitkäniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 1994; 23: 1315-21.
23. Hahn D, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae coronary artery disease association. Arterioscler Thromb 1992; 12: 945-7.
24. Kaprio J, Sarna S, Koskenvuo M, Rantasalo I. The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity. determination procedures, and research program. In: Nance WE, ed. Twin Research: Biology and Epidemiology. New York, USA: Alan R Liss. 1978:179-84.
25. Sarna S, Kaprio J, Sistonen P, Koskenvuo M. Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 1978; 28; 241-54.
26. Hublin C, Kaprio J, Partinen J, Koskenvuo M, Heikkilä S, Koskimies S, Guilleminault C. The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol 1994; 35: 709-16.
27. Haapanen A, Koskenvuo M, Kaprio J, Kesäniemi YA, Heikkilä K. Carotid arteriosclerosis in identical twins discordant for cigarette smoking. Circulation 1989; 80: 10-6.
28. Battié MC, Videman T, Gill K, Moneta GB, Nyman R, Kaprio J, Koskenvuo M, Smoking and lumbar intervertebral disc degeneration: An MRI study of identical twins. Spine 1991; 16: 1015-21.
29. von Hertzen L, Leinonen M, Surcel H-M, Karjalainen J, Saikku P. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clin Diagn Lab Immun 1995; 2: 454-7.
30. Jauhiainen T, Tuomi T, Leinonen M, Kark JD, Saikku P. Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations for Chlamydia pneumoniae by micro-immunofluorescence test. J Clin Microbiol 1994; 32: 839-40.
31. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992; 25 (Suppl.): 27-34.
32. Wolf HM, Fischer MB, Pühringer H, Samstag A, Vogel E, Eibl MM. Human serum IgA downregulates the release of inlammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. Blood 1994; 83: 1278-88.
33. Briere F, Bridon JM, Chevet D, Souillet G, Bienvenu F, Guret C et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994; 94: 97-104.
34. Umetsu DT, DeKruyff RH. Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases. Proc Soc Exp Biol Med 1997; 215: 11-20.
35. Madretsma GS, Donze GJ, van Dijk APM, Tak CJ, W. Ilson JHP, Zijlstra FJ. Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-α by human mononuclear cells. Immunopharmacol 1996; 35: 47-51.
36. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994; 150: 696-703.
37. Laurila AL, Anttila T, Läärä E, Bloigu A, Virtamo J, Albanes D et al. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer 1997; 74: 31-4.
38. Harris CC. Tobacco smoke and lung disease: who is susceptible? Ann Intern Med 1986; 105: 607-8.
39. Blake GH, Abell TD, Stanley WG. Cigarette smoking and upper respiratory infection among recruits in basic combat training. Ann Intern Med 1988; 109: 198-202.
40. Rothermel CD, Schachter J, Lavrich P, Lipsitz EC, Francus T. Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immunol 1989; 57: 2705-11.